Cellmid directors show faith in company by participating in share placement
Imugene presents HER2 immuno-oncology vaccines success at ESMO ahead of 2020 studies
THC Global Group progresses core drivers of revenue growth
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.